Evidence map›Paper›PMID 37121979›Full record

ArticleExperimental & molecular medicine2023

Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease.

Jong-Chan Park, Hanbyeol Lim, Min Soo Byun, Dahyun Yi, Gihwan Byeon, Gijung Jung, Yu Kyeong Kim, Dong Young Lee, Sun-Ho Han, Inhee Mook-Jung

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Sex differences inFrontiers in dementia · 2025
    Pooled it
  2. Trial
  3. Article
  4. HyperpolarizedResearch square · 2026
    Article
  5. Sex differences in brain glucose metabolism and Alzheimer's disease risk and progression.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  6. Review
  7. Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Jong-Chan ParkDepartment of Biophysics, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Hanbyeol LimDepartment of Medicine, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Min Soo ByunDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Dahyun YiDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Gihwan ByeonDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Gijung JungDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Yu Kyeong KimDepartment of Nuclear Medicine, SMG-SNU Boramae Medical Center, Seoul, 07061, Republic of Korea.
Dong Young LeeDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Sun-Ho HanDepartment of Biochemistry and Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea. sunho@snu.ac.kr.
Inhee Mook-JungDepartment of Biochemistry and Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea. inhee@snu.ac.kr.ORCID http://orcid.org/0000-0001-7085-4085
Seoul National University · KRSeoul National University Hospital · KRSNUH SMG-SNU Boramae Medical Center · KRSungkyunkwan University · KR

Funding

KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems BiologyU01AG072177 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LEE, DONG YOUNG, NHO, KWANGSIK TIMOTHY · 2021 to 2025
$11.2M
NIA NIH HHS U01 AG072177
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disease characterized by amyloid plaques and impaired brain metabolism. Because women have a higher prevalence of AD than men, sex differences are of great interest. Using cross-sectional and longitudinal data, we showed sex-dependent metabolic dysregulations in the brains of AD patients. Cohort 1 (South Korean, n = 181) underwent Pittsburgh compound B-PET, fluorodeoxyglucose-PET, magnetic resonance imaging, and blood biomarker (plasma tau and beta-amyloid 42 and 40) measurements at baseline and two-year follow-ups. Transcriptome analysis of data from Cohorts 2 and 3 (European, n = 78; Singaporean, n = 18) revealed sex differences in AD-related alterations in brain metabolism. In women (but not in men), all imaging indicators displayed consistent correlation curves with AD progression. At the two-year follow-up, clear brain metabolic impairment was revealed only in women, and the plasma beta-amyloid 42/40 ratio was a possible biomarker for brain metabolism in women. Furthermore, our transcriptome analysis revealed sex differences in transcriptomes and metabolism in the brains of AD patients as well as a molecular network of 25 female-specific glucose metabolic genes (FGGs). We discovered four key-attractor FGG genes (ALDOA, ENO2, PRKACB, and PPP2R5D) that were associated with amyloid/tau-related genes (APP, MAPT, BACE1, and BACE2). Furthermore, these genes successfully distinguished amyloid positivity in women. Understanding sex differences in the pathogenesis of AD and considering these differences will improve development of effective diagnostics and therapeutic treatments for AD.

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesAmyloidAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBiomarkersBrainCross-Sectional StudiesDisease ProgressionFemaleGlucoseHumansMaleProtein Phosphatase 2Sex CharacteristicsAmyloidAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBiomarkersGlucosePPP2R5D protein, humanProtein Phosphatase 2tau Proteins

Identifiers

PMID37121979
PMCPMC10238450
OpenAlexW4367548858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.